Short Interest in Hypermarcas (OTCMKTS:HYPMY) Expands By 3,300.0%

Hypermarcas (OTCMKTS:HYPMY) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 544 shares, an increase of 3,300.0% from the December 31st total of 16 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 4,007 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 4,007 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.

Hypermarcas Trading Up 6.7%

Shares of HYPMY stock opened at $5.32 on Thursday. The firm has a 50-day moving average price of $4.52 and a 200 day moving average price of $4.44. Hypermarcas has a twelve month low of $3.04 and a twelve month high of $5.32. The company has a market capitalization of $3.37 billion, a price-to-earnings ratio of 23.13 and a beta of 0.72. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. The company had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.